Results 251 to 260 of about 149,243 (305)

Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular Carcinoma

Liver International, Volume 46, Issue 7, July 2026.
ABSTRACT Background Comorbidities might limit therapeutic options and negatively impact survival in patients with hepatocellular carcinoma (HCC). The Charlson Comorbidity Index (CCI) is widely used to summarize and quantify comorbidities. Methods HCC patients diagnosed between 1992 and 2018 at the Medical University of Vienna were retrospectively ...
Tobias Meischl, Moritz Steurer, Lorenz Balcar, Yannick Marcour, Patrick Meier, Lukas Bucher, Ye‐Rin Park, Katharina Pomej, Mattias Mandorfer, Thomas Reiberger, Michael Trauner, Bernhard Scheiner, Matthias Pinter   +12 more
wiley   +1 more source

Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’

Vox Sanguinis, EarlyView.
Ramune Sepetiene, Mohamed Ali, Guillermo Orjuela, Ted Kieffer, Ellen Ollson, Axel Stover, Jason Kang   +6 more
wiley   +1 more source

Socioeconomic Factors and Their Role in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Comprehensive Review

Liver International, Volume 46, Issue 7, July 2026.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD), a major public health concern, is influenced by an interplay of genetic, environmental, and lifestyle factors, with socioeconomic factors functioning as important upstream determinants whose roles remain not yet fully understood.
Leke Wiering, Münevver Demir
wiley   +1 more source

Validation of Risk Models for Predicting Post‐SVR HCC in Real‐World Surveillance Across Global Geographic Regions

Liver International, Volume 46, Issue 7, July 2026.
ABSTRACT Background & Aims Several clinical risk models have been proposed to stratify hepatocellular carcinoma (HCC) risk in patients with chronic hepatitis C virus (HCV) after sustained virologic response (SVR). However, validation efforts have focused on monocentric or country‐specific cohorts, and it is unclear if clinical risk models can be ...
Hidenori Toyoda, Yujin Hoshida, Neehar D. Parikh, Prasun K. Jalal, Federico Piñero, Manuel Mendizabal, Ezequiel Ridruejo, Hugo Cheinquer, Andrea Casadei‐Gardini, Mounika Kanneganti, Arndt Weinmann, Markus Peck‐Radosavljevic, Jean‐Francois Dufour, Pompilia Radu, Gamal Shiha, Riham Soliman, Shiv K. Sarin, Manoj Kumar, Jing‐Houng Wang, Pisit Tangkijvanich, Wattana Sukeepaisarnjaroen, Masanori Atsukawa, Haruki Uojima, Akito Nozaki, Makoto Nakamuta, Koichi Takaguchi, Atsushi Hiraoka, Hiroshi Abe, Kentaro Matsuura, Tsunamasa Watanabe, Noritomo Shimada, Kunihiko Tsuji, Toru Ishikawa, Shigeru Mikami, Ei Itobayashi, Philip J. Johnson, Amit G. Singal   +36 more
wiley   +1 more source

Liver Transplantation for HBV‐Related Disease in France: NUC Type Before LT Is Associated With Patient Survival

Liver International, Volume 46, Issue 7, July 2026.
ABSTRACT Background & Aims Liver transplantation (LT) is indicated for liver complications related to hepatitis B virus (HBV) infection: acute liver failure (ALF), decompensated cirrhosis or hepatocellular carcinoma (HCC). The present study aimed to describe and evaluate patient survival after LT for HBV‐related disease in France and identify the ...
Isaure Bienvenue, Olivier Roux, Audrey Coilly, Armand Abergel, Teresa Antonini, Thierry Artzner, Olivier Boillot, Faiza Chermak, Filomena Conti, Sébastien Dharancy, Christophe Duvoux, Laure Elkrief, Marwin Farrugia, Claire Francoz, Baptiste Giguet, Jean Hardwigsen, Pauline Houssel‐Debry, Marie‐Noëlle Hilleret, Nassim Kamar, Marianne Latournerie, Magdalena Meszaros, Sylvie Radenne, Bruno Roche, Ephrem Salamé, Delphine Verhoeven‐Weil, Didier Samuel, Fabien Zoulim, Jérôme Dumortier, François Villeret   +28 more
wiley   +1 more source

Mortality Attributable to Hepatitis B and C in Italy, Romania, and Spain, 2022 Estimates

Liver International, Volume 46, Issue 7, July 2026.
ABSTRACT Background and Aims Reliable data on viral hepatitis–related deaths remain limited, challenging assessment of progress towards the WHO elimination targets for mortality. To address this gap, we estimated hepatitis B‐ and C‐attributable mortality in Italy, Romania, and Spain for 2022.
Oleksandr Korotych, Helene Høgsbro Thygesen, Otilia Mårdh, Juliana Reyes‐Urueña, Gaetano Marrone, Jürgen Rockstroh, Marie‐Louise Jakobsen, Catherine de Martel, Loreta A. Kondili, Maria Giovanna Quaranta, Benedetta Mattioli, Stefano Rosato, Maria Rendina, Antonella De Feudis, Valentina Cossiga, Simona Albano, Filomena Morisco, Mauro Viganò, Alessandro Loglio, Stefano Fagiuoli, Vincenza Calvaruso, Ciro Celsa, Francesco Longobardi, Roberta Coppola, Francesco Paolo Russo, Sara Battistella, Nicola Coppola, Caterina Sagnelli, Barbara Coco, Maurizia Rossana Brunetto, Odette Popovici, Denisa Janță, Cristian Calomfirescu, Liana Simona Gheorghe, Mihaela Ghioca, Carmen Ester, Mirela Chitul, Razvan Cerban, Anca Trifan, Laura Huiban, Cristina Muzica, Alina Popescu, Roxana Sirli, Camelia Nica, Alexandru Popa, Maria Buti Ferret, Elena Vargas‐Accarino, Asuncion Díaz, Catalina Fernández Méndez, Luis Morano, Sonia Alonso, Adriana Ahumada, Rafael Bañares Cañizares, Dorthe Raben, Erika Duffell   +54 more
wiley   +1 more source

A new hepatitis agent: hepatitis C virus (HCV)

Tropical gastroenterology : official journal of the Digestive Diseases Foundation, 1991
openaire   +1 more source

Hepatitis C. Seroprevalence of hepatitis C virus (HCV) in a population sample.

Releve epidemiologique hebdomadaire, 1997
openaire   +1 more source